GURUFOCUS.COM » STOCK LIST » Creative Antibiotics AB (OSTO:CAS) » Definitions » Research & Development

Creative Antibiotics AB (OSTO:CAS) Research & Development : kr0.00 Mil (TTM As of Mar. 2013)


View and export this data going back to . Start your Free Trial

What is Creative Antibiotics AB Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Creative Antibiotics AB's Research & Development for the three months ended in Mar. 2013 was kr0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2013 was kr0.00 Mil.


Creative Antibiotics AB Research & Development Historical Data

The historical data trend for Creative Antibiotics AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creative Antibiotics AB Research & Development Chart

Creative Antibiotics AB Annual Data
Trend Jun08 Jun09 Jun10 Dec11
Research & Development
- - - -

Creative Antibiotics AB Quarterly Data
Jun08 Mar09 Jun09 Sep09 Dec09 Mar10 Sep10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Mar13
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Creative Antibiotics AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Creative Antibiotics AB  (OSTO:CAS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Creative Antibiotics AB Research & Development Related Terms

Thank you for viewing the detailed overview of Creative Antibiotics AB's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.